These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
747 related articles for article (PubMed ID: 11948401)
1. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers. Suzukawa K; Colburn NH Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401 [TBL] [Abstract][Full Text] [Related]
2. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes. Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737 [TBL] [Abstract][Full Text] [Related]
3. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos. Echlin DR; Tae HJ; Mitin N; Taparowsky EJ Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element. Li JJ; Dong Z; Dawson MI; Colburn NH Cancer Res; 1996 Feb; 56(3):483-9. PubMed ID: 8564958 [TBL] [Abstract][Full Text] [Related]
5. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells. Agadir A; Shealy YF; Hill DL; Zhang X Cancer Res; 1997 Aug; 57(16):3444-50. PubMed ID: 9270011 [TBL] [Abstract][Full Text] [Related]
6. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells]. Chuĭkin IA; Lianguzova MS; Pospelov VA Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838 [TBL] [Abstract][Full Text] [Related]
7. c-Jun and c-Fos cooperate with STAT3 in IL-6-induced transactivation of the IL-6 respone element (IRE). Schuringa JJ; Timmer H; Luttickhuizen D; Vellenga E; Kruijer W Cytokine; 2001 Apr; 14(2):78-87. PubMed ID: 11356008 [TBL] [Abstract][Full Text] [Related]
8. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin. Chun KS; Kim SH; Song YS; Surh YJ Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583 [TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es). Farina AR; Cappabianca L; Mackay AR; Tiberio A; Tacconelli A; Tessitore A; Frati L; Martinotti S; Gulino A Cell Growth Differ; 1997 Jul; 8(7):789-800. PubMed ID: 9218873 [TBL] [Abstract][Full Text] [Related]
11. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model. Zoumpourlis V; Papassava P; Linardopoulos S; Gillespie D; Balmain A; Pintzas A Oncogene; 2000 Aug; 19(35):4011-21. PubMed ID: 10962557 [TBL] [Abstract][Full Text] [Related]
12. Mitogen activated protein kinase-dependent activation of c-Jun and c-Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells. Eriksson M; Taskinen M; Leppä S J Cell Physiol; 2007 Feb; 210(2):538-48. PubMed ID: 17111371 [TBL] [Abstract][Full Text] [Related]
14. MEKK1 regulates the AP-1 dimer repertoire via control of JunB transcription and Fra-2 protein stability. Cuevas BD; Uhlik MT; Garrington TP; Johnson GL Oncogene; 2005 Jan; 24(5):801-9. PubMed ID: 15558021 [TBL] [Abstract][Full Text] [Related]
15. Modulation of transcription factor AP-1 activity in murine EL-4 thymoma cells by vomitoxin (deoxynivalenol). Li S; Ouyang Y; Yang GH; Pestka JJ Toxicol Appl Pharmacol; 2000 Feb; 163(1):17-25. PubMed ID: 10662601 [TBL] [Abstract][Full Text] [Related]
16. Opposing activities of c-Fos and Fra-2 on AP-1 regulated transcriptional activity in mouse keratinocytes induced to differentiate by calcium and phorbol esters. Rutberg SE; Saez E; Lo S; Jang SI; Markova N; Spiegelman BM; Yuspa SH Oncogene; 1997 Sep; 15(11):1337-46. PubMed ID: 9315102 [TBL] [Abstract][Full Text] [Related]
17. cFos is critical for MCF-7 breast cancer cell growth. Lu C; Shen Q; DuPré E; Kim H; Hilsenbeck S; Brown PH Oncogene; 2005 Sep; 24(43):6516-24. PubMed ID: 16027729 [TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of a dominant-negative mutant of c-Jun. Brown PH; Chen TK; Birrer MJ Oncogene; 1994 Mar; 9(3):791-9. PubMed ID: 8108121 [TBL] [Abstract][Full Text] [Related]
19. Activation and inhibition of the AP-1 complex in human breast cancer cells. Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534 [TBL] [Abstract][Full Text] [Related]
20. Dietary energy restriction, in part through glucocorticoid hormones, mediates the impact of 12-O-tetradecanoylphorbol-13-acetate on jun D and fra-1 in Sencar mouse epidermis. Przybyszewski J; Wang W; Au A; Perry C; Guetzko M; Koehler K; Birt DF Mol Carcinog; 2010 Jun; 49(6):592-602. PubMed ID: 20232358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]